Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Measurable Residual Disease Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Flow Cytometry Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measurable Residual Disease Testing include Adaptive Biotechnologies Corporation, ArcherDX, Inc. (Invitae Corporation), Asuragen, Arup Laboratories, Bio-Rad Laboratories, Cergentis B.V., F. Hoffmann- La Roche Ltd, Guardant Health and ICON plc, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Measurable residual disease (also known as “minimal residual disease”) refers to the number of cancer cells that remain during and after cancer treatment. Complete remission (less than 5% blasts in bone marrow) by morphologic assessment is not enough to accurately depict remaining malignant cells.
This report aims to provide a comprehensive presentation of the global market for Measurable Residual Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measurable Residual Disease Testing. This report contains market size and forecasts of Measurable Residual Disease Testing in global, including the following market information:
Global Measurable Residual Disease Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measurable Residual Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measurable Residual Disease Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Measurable Residual Disease Testing Market Segment Percentages, by Type, 2022 (%)
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other
Global Measurable Residual Disease Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Measurable Residual Disease Testing Market Segment Percentages, by Application, 2022 (%)
Hematological Malignancies
Leukemia
Lymphoma
Solid Tumors
Other
Global Measurable Residual Disease Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Measurable Residual Disease Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measurable Residual Disease Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Measurable Residual Disease Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Adaptive Biotechnologies Corporation
ArcherDX, Inc. (Invitae Corporation)
Asuragen
Arup Laboratories
Bio-Rad Laboratories
Cergentis B.V.
F. Hoffmann- La Roche Ltd
Guardant Health
ICON plc
Invivoscribe
Laboratory Corporation of America Holdings
Mission Bio
Natera, Inc.
NeoGenomics Laboratories
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Genetron Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measurable Residual Disease Testing, market overview.
Chapter 2: Global Measurable Residual Disease Testing market size in revenue.
Chapter 3: Detailed analysis of Measurable Residual Disease Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measurable Residual Disease Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Measurable Residual Disease Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measurable Residual Disease Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measurable Residual Disease Testing Overall Market Size
2.1 Global Measurable Residual Disease Testing Market Size: 2022 VS 2029
2.2 Global Measurable Residual Disease Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Measurable Residual Disease Testing Players in Global Market
3.2 Top Global Measurable Residual Disease Testing Companies Ranked by Revenue
3.3 Global Measurable Residual Disease Testing Revenue by Companies
3.4 Top 3 and Top 5 Measurable Residual Disease Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Measurable Residual Disease Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Measurable Residual Disease Testing Players in Global Market
3.6.1 List of Global Tier 1 Measurable Residual Disease Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Measurable Residual Disease Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Measurable Residual Disease Testing Market Size Markets, 2022 & 2029
4.1.2 Flow Cytometry
4.1.3 Polymerase Chain Reaction (PCR)
4.1.4 Next-Generation Sequencing (NGS)
4.1.5 Other
4.2 By Type - Global Measurable Residual Disease Testing Revenue & Forecasts
4.2.1 By Type - Global Measurable Residual Disease Testing Revenue, 2018-2023
4.2.2 By Type - Global Measurable Residual Disease Testing Revenue, 2024-2029
4.2.3 By Type - Global Measurable Residual Disease Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Measurable Residual Disease Testing Market Size, 2022 & 2029
5.1.2 Hematological Malignancies
5.1.3 Leukemia
5.1.4 Lymphoma
5.1.5 Solid Tumors
5.1.6 Other
5.2 By Application - Global Measurable Residual Disease Testing Revenue & Forecasts
5.2.1 By Application - Global Measurable Residual Disease Testing Revenue, 2018-2023
5.2.2 By Application - Global Measurable Residual Disease Testing Revenue, 2024-2029
5.2.3 By Application - Global Measurable Residual Disease Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Measurable Residual Disease Testing Market Size, 2022 & 2029
6.2 By Region - Global Measurable Residual Disease Testing Revenue & Forecasts
6.2.1 By Region - Global Measurable Residual Disease Testing Revenue, 2018-2023
6.2.2 By Region - Global Measurable Residual Disease Testing Revenue, 2024-2029
6.2.3 By Region - Global Measurable Residual Disease Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Measurable Residual Disease Testing Revenue, 2018-2029
6.3.2 US Measurable Residual Disease Testing Market Size, 2018-2029
6.3.3 Canada Measurable Residual Disease Testing Market Size, 2018-2029
6.3.4 Mexico Measurable Residual Disease Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Measurable Residual Disease Testing Revenue, 2018-2029
6.4.2 Germany Measurable Residual Disease Testing Market Size, 2018-2029
6.4.3 France Measurable Residual Disease Testing Market Size, 2018-2029
6.4.4 U.K. Measurable Residual Disease Testing Market Size, 2018-2029
6.4.5 Italy Measurable Residual Disease Testing Market Size, 2018-2029
6.4.6 Russia Measurable Residual Disease Testing Market Size, 2018-2029
6.4.7 Nordic Countries Measurable Residual Disease Testing Market Size, 2018-2029
6.4.8 Benelux Measurable Residual Disease Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Measurable Residual Disease Testing Revenue, 2018-2029
6.5.2 China Measurable Residual Disease Testing Market Size, 2018-2029
6.5.3 Japan Measurable Residual Disease Testing Market Size, 2018-2029
6.5.4 South Korea Measurable Residual Disease Testing Market Size, 2018-2029
6.5.5 Southeast Asia Measurable Residual Disease Testing Market Size, 2018-2029
6.5.6 India Measurable Residual Disease Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Measurable Residual Disease Testing Revenue, 2018-2029
6.6.2 Brazil Measurable Residual Disease Testing Market Size, 2018-2029
6.6.3 Argentina Measurable Residual Disease Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Measurable Residual Disease Testing Revenue, 2018-2029
6.7.2 Turkey Measurable Residual Disease Testing Market Size, 2018-2029
6.7.3 Israel Measurable Residual Disease Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Measurable Residual Disease Testing Market Size, 2018-2029
6.7.5 UAE Measurable Residual Disease Testing Market Size, 2018-2029
7 Measurable Residual Disease Testing Companies Profiles
7.1 Adaptive Biotechnologies Corporation
7.1.1 Adaptive Biotechnologies Corporation Company Summary
7.1.2 Adaptive Biotechnologies Corporation Business Overview
7.1.3 Adaptive Biotechnologies Corporation Measurable Residual Disease Testing Major Product Offerings
7.1.4 Adaptive Biotechnologies Corporation Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.1.5 Adaptive Biotechnologies Corporation Key News & Latest Developments
7.2 ArcherDX, Inc. (Invitae Corporation)
7.2.1 ArcherDX, Inc. (Invitae Corporation) Company Summary
7.2.2 ArcherDX, Inc. (Invitae Corporation) Business Overview
7.2.3 ArcherDX, Inc. (Invitae Corporation) Measurable Residual Disease Testing Major Product Offerings
7.2.4 ArcherDX, Inc. (Invitae Corporation) Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.2.5 ArcherDX, Inc. (Invitae Corporation) Key News & Latest Developments
7.3 Asuragen
7.3.1 Asuragen Company Summary
7.3.2 Asuragen Business Overview
7.3.3 Asuragen Measurable Residual Disease Testing Major Product Offerings
7.3.4 Asuragen Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.3.5 Asuragen Key News & Latest Developments
7.4 Arup Laboratories
7.4.1 Arup Laboratories Company Summary
7.4.2 Arup Laboratories Business Overview
7.4.3 Arup Laboratories Measurable Residual Disease Testing Major Product Offerings
7.4.4 Arup Laboratories Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.4.5 Arup Laboratories Key News & Latest Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Summary
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories Measurable Residual Disease Testing Major Product Offerings
7.5.4 Bio-Rad Laboratories Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.5.5 Bio-Rad Laboratories Key News & Latest Developments
7.6 Cergentis B.V.
7.6.1 Cergentis B.V. Company Summary
7.6.2 Cergentis B.V. Business Overview
7.6.3 Cergentis B.V. Measurable Residual Disease Testing Major Product Offerings
7.6.4 Cergentis B.V. Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.6.5 Cergentis B.V. Key News & Latest Developments
7.7 F. Hoffmann- La Roche Ltd
7.7.1 F. Hoffmann- La Roche Ltd Company Summary
7.7.2 F. Hoffmann- La Roche Ltd Business Overview
7.7.3 F. Hoffmann- La Roche Ltd Measurable Residual Disease Testing Major Product Offerings
7.7.4 F. Hoffmann- La Roche Ltd Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.7.5 F. Hoffmann- La Roche Ltd Key News & Latest Developments
7.8 Guardant Health
7.8.1 Guardant Health Company Summary
7.8.2 Guardant Health Business Overview
7.8.3 Guardant Health Measurable Residual Disease Testing Major Product Offerings
7.8.4 Guardant Health Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.8.5 Guardant Health Key News & Latest Developments
7.9 ICON plc
7.9.1 ICON plc Company Summary
7.9.2 ICON plc Business Overview
7.9.3 ICON plc Measurable Residual Disease Testing Major Product Offerings
7.9.4 ICON plc Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.9.5 ICON plc Key News & Latest Developments
7.10 Invivoscribe
7.10.1 Invivoscribe Company Summary
7.10.2 Invivoscribe Business Overview
7.10.3 Invivoscribe Measurable Residual Disease Testing Major Product Offerings
7.10.4 Invivoscribe Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.10.5 Invivoscribe Key News & Latest Developments
7.11 Laboratory Corporation of America Holdings
7.11.1 Laboratory Corporation of America Holdings Company Summary
7.11.2 Laboratory Corporation of America Holdings Business Overview
7.11.3 Laboratory Corporation of America Holdings Measurable Residual Disease Testing Major Product Offerings
7.11.4 Laboratory Corporation of America Holdings Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.11.5 Laboratory Corporation of America Holdings Key News & Latest Developments
7.12 Mission Bio
7.12.1 Mission Bio Company Summary
7.12.2 Mission Bio Business Overview
7.12.3 Mission Bio Measurable Residual Disease Testing Major Product Offerings
7.12.4 Mission Bio Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.12.5 Mission Bio Key News & Latest Developments
7.13 Natera, Inc.
7.13.1 Natera, Inc. Company Summary
7.13.2 Natera, Inc. Business Overview
7.13.3 Natera, Inc. Measurable Residual Disease Testing Major Product Offerings
7.13.4 Natera, Inc. Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.13.5 Natera, Inc. Key News & Latest Developments
7.14 NeoGenomics Laboratories
7.14.1 NeoGenomics Laboratories Company Summary
7.14.2 NeoGenomics Laboratories Business Overview
7.14.3 NeoGenomics Laboratories Measurable Residual Disease Testing Major Product Offerings
7.14.4 NeoGenomics Laboratories Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.14.5 NeoGenomics Laboratories Key News & Latest Developments
7.15 Opko Health
7.15.1 Opko Health Company Summary
7.15.2 Opko Health Business Overview
7.15.3 Opko Health Measurable Residual Disease Testing Major Product Offerings
7.15.4 Opko Health Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.15.5 Opko Health Key News & Latest Developments
7.16 Quest Diagnostics Incorporated
7.16.1 Quest Diagnostics Incorporated Company Summary
7.16.2 Quest Diagnostics Incorporated Business Overview
7.16.3 Quest Diagnostics Incorporated Measurable Residual Disease Testing Major Product Offerings
7.16.4 Quest Diagnostics Incorporated Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.16.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.17 Sysmex Corporation
7.17.1 Sysmex Corporation Company Summary
7.17.2 Sysmex Corporation Business Overview
7.17.3 Sysmex Corporation Measurable Residual Disease Testing Major Product Offerings
7.17.4 Sysmex Corporation Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.17.5 Sysmex Corporation Key News & Latest Developments
7.18 Genetron Health
7.18.1 Genetron Health Company Summary
7.18.2 Genetron Health Business Overview
7.18.3 Genetron Health Measurable Residual Disease Testing Major Product Offerings
7.18.4 Genetron Health Measurable Residual Disease Testing Revenue in Global Market (2018-2023)
7.18.5 Genetron Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
